Published in J Infect Dis on February 01, 1984
Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun (1985) 2.23
Rhizobium leguminosarum CFN42 genetic regions encoding lipopolysaccharide structures essential for complete nodule development on bean plants. J Bacteriol (1989) 2.00
Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect Immun (1992) 1.76
Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence. Infect Immun (1987) 1.38
Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev (1989) 1.32
Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect Immun (2008) 1.32
Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum. Infect Immun (1985) 1.27
Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect Immun (1987) 1.16
Protein I: structure, function, and genetics. Clin Microbiol Rev (1989) 1.14
Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide. Infect Immun (1999) 1.14
Differential regulation of ponA and pilMNOPQ expression by the MtrR transcriptional regulatory protein in Neisseria gonorrhoeae. J Bacteriol (2007) 1.12
Tn916-generated, lipooligosaccharide mutants of Neisseria meningitidis and Neisseria gonorrhoeae. Infect Immun (1994) 1.10
Cloning of a gonococcal DNA sequence that complements the lipooligosaccharide defects of Neisseria gonorrhoeae 1291d and 1291e. Infect Immun (1993) 1.08
Aeromonas salmonicida resistance to complement-mediated killing. Infect Immun (1994) 1.05
The construction and characterization of Neisseria gonorrhoeae lacking protein III in its outer membrane. J Exp Med (1989) 1.05
Defining targets for complement components C4b and C3b on the pathogenic neisseriae. Infect Immun (2007) 1.03
Stable expression of lipooligosaccharide antigens during attachment, internalization, and intracellular processing of Neisseria gonorrhoeae in infected epithelial cells. Infect Immun (1989) 1.03
Molecular analysis of lipooligosaccharide biosynthesis in Neisseria gonorrhoeae. Infect Immun (1989) 1.03
A recombinant molecule from a disseminating strain of Neisseria gonorrhoeae that confers serum bactericidal resistance. Infect Immun (1987) 1.01
Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing. Infect Immun (1996) 0.99
Neisseria gonorrhoeae modulates iron-limiting innate immune defenses in macrophages. PLoS One (2014) 0.99
Analysis of the lsi region involved in lipooligosaccharide biosynthesis in Neisseria gonorrhoeae. J Bacteriol (1991) 0.98
Lipooligosaccharide Structure is an Important Determinant in the Resistance of Neisseria Gonorrhoeae to Antimicrobial Agents of Innate Host Defense. Front Microbiol (2011) 0.98
A mutation in the Neisseria gonorrhoeae rfaD homolog results in altered lipooligosaccharide expression. J Bacteriol (1995) 0.98
Characterization of Neisseria gonorrhoeae reference strains used in development of serologic classification systems. J Clin Microbiol (1988) 0.94
Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate. Infect Immun (1992) 0.93
Polyamines can increase resistance of Neisseria gonorrhoeae to mediators of the innate human host defense. Infect Immun (2010) 0.92
Introduction of cloned genes into Neisseria gonorrhoeae. Clin Microbiol Rev (1989) 0.91
Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein. J Immunol (2012) 0.91
Effects of human serum on bacterial competition with neutrophils for molecular oxygen. Infect Immun (1986) 0.90
Humoral immune response to gonococcal infections. Clin Microbiol Rev (1989) 0.86
Use of xylE fusions to demonstrate that lsi-1, a Neisseria gonorrhoeae lipooligosaccharide biosynthetic gene, and lsi-3 are not transcriptionally linked. J Bacteriol (1994) 0.81
Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains. Infect Immun (1988) 0.80
Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen. J Clin Invest (1989) 0.78
Characterization of a spermine/spermidine transport system reveals a novel DNA sequence duplication in Neisseria gonorrhoeae. FEMS Microbiol Lett (2015) 0.75
Phosphoethanolamine Modification of Neisseria gonorrhoeae Lipid A Reduces Autophagy Flux in Macrophages. PLoS One (2015) 0.75
Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A (1992) 16.64
Genetic transformation of Neisseria gonorrhoeae to streptomycin resistance. J Bacteriol (1966) 8.51
Functional mapping of the human visual cortex by magnetic resonance imaging. Science (1991) 6.93
Sexual transmission of HIV. N Engl J Med (1997) 6.84
Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med (2000) 6.72
Multiple antibiotic resistance due to a single mutation in Neisseria gonorrhoeae. J Infect Dis (1973) 5.17
Inheritance of low-level resistance to penicillin, tetracycline, and chloramphenicol in Neisseria gonorrhoeae. J Bacteriol (1975) 5.02
Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology (1995) 4.93
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (2000) 4.91
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol (1989) 4.48
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect Immun (1981) 4.28
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
Genetic mapping of linked antibiotic resistance loci in Neisseria gonorrhoeae. J Bacteriol (1974) 4.13
Genetics of staphylococcal enterotoxin B in methicillin-resistant isolates of Staphylococcus aureus. Infect Immun (1979) 3.71
Cell envelope alterations in antibiotic-sensitive and-resistant strains of Neisseria gonorrhoeae. J Bacteriol (1978) 3.71
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis (1998) 3.46
Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS (1997) 3.42
Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun (1984) 3.32
The microbicidal mechanisms of human neutrophils and eosinophils. Rev Infect Dis (1981) 3.29
Diagnosis and treatment of syphilis. N Engl J Med (1971) 3.28
Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin. Infect Immun (1982) 3.27
Colonial morphology of Neisseria gonorrhoeae isolated from males and females. J Bacteriol (1967) 3.22
Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB-dependent outer membrane receptors. J Bacteriol (1992) 3.21
The human mannose-binding protein functions as an opsonin. J Exp Med (1989) 3.15
Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis (1999) 3.12
Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol (1982) 3.11
DNA transformation leads to pilin antigenic variation in Neisseria gonorrhoeae. Nature (1988) 2.98
Response of Neisseria gonorrhoeae to iron limitation: alterations in expression of membrane proteins without apparent siderophore production. Infect Immun (1985) 2.94
Antibiotic resistance in Neisseria gonorrhoeae. Med Clin North Am (1972) 2.89
A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N Engl J Med (1985) 2.85
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Preventing sexual transmission of HIV--new ideas from sub-Saharan Africa. N Engl J Med (2000) 2.67
Species-specific uptake of DNA by gonococci is mediated by a 10-base-pair sequence. J Bacteriol (1991) 2.64
The genetics of the gonococcus. Annu Rev Microbiol (1984) 2.63
Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J Bacteriol (1995) 2.60
Sexual transmission of HIV: infectiousness and prevention. AIDS (1999) 2.59
Kasugamycin resistance: 30S ribosomal mutation with an unusual location on the Escherichia coli chromosome. Science (1970) 2.57
Altered outer membrane protein in different colonial types of Neisseria gonorrhoeae. J Bacteriol (1977) 2.54
Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol (1994) 2.53
Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS (1997) 2.51
Bacterial adaptation to oxidative stress: implications for pathogenesis and interaction with phagocytic cells. FASEB J (1989) 2.47
Factors affecting genetic transformation of Neisseria gonorrhoeae. J Bacteriol (1977) 2.45
Loss of low-level antibiotic resistance in Neisseria gonorrhoeae due to env mutations. J Bacteriol (1975) 2.43
Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect (2004) 2.43
Lipid A and resistance of Salmonella typhimurium to antimicrobial granule proteins of human neutrophil granulocytes. Infect Immun (1984) 2.41
Molecular cloning and characterization of the structural gene for protein I, the major outer membrane protein of Neisseria gonorrhoeae. Proc Natl Acad Sci U S A (1987) 2.40
The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol Microbiol (1998) 2.33
Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization. J Bacteriol (1994) 2.32
Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med (1981) 2.31
Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. Proc Natl Acad Sci U S A (1988) 2.27
Growth inhibition among strains of Neisseria gonorrhoeae due to production of inhibitory free fatty acids and lysophosphatidylethanolamine: absence of bacteriocins. Infect Immun (1974) 2.25
Single doses of methacycline and doxycycline for gonorrhea: a cooperative study of the frequency and cause of treatment failure. J Infect Dis (1973) 2.23
Conjugal transfer of the gonococcal penicillinase plasmid. Science (1977) 2.22
Conjugative plasmids in Neisseria gonorrhoeae. J Bacteriol (1978) 2.19
Regulation of staphylococcal enterotoxin B. Infect Immun (1977) 2.16
Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med (1990) 2.14
Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen. J Bacteriol (1984) 2.12
Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods (1996) 2.12
Spectinomycin sulfate and aqueous procaine penicillin G in treatment of female gonorrhea. Antimicrob Agents Chemother (Bethesda) (1965) 2.11
Penicillin sensitivity and serum resistance are independent attributes of strains of Neisseria gonorrhoeae causing disseminated gonococcal infection. Infect Immun (1977) 2.09
Response of Pseudomonas aeruginosa to pyocyanin: mechanisms of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase. Infect Immun (1992) 2.09
Closed reduction and percutaneous pinning of fractures of the proximal phalanx. J Hand Surg Br (2001) 2.07
Effects of serum carrier proteins on the growth of pathogenic neisseriae with heme-bound iron. Infect Immun (1987) 2.05
Altered crystal violet permeability and lytic behavior in antibiotic-resistant and -sensitive mutants of Neisseria gonorrhoeae. J Bacteriol (1975) 2.04
Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae. Infect Immun (1988) 2.02
Ribosomal resistance to streptomycin and spectinomycin in Neisseria gonorrhoeae. J Bacteriol (1974) 1.96
Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. J Bacteriol (1990) 1.94
Haemophilus influenzae can use human transferrin as a sole source for required iron. Infect Immun (1985) 1.94
Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J Clin Invest (1994) 1.93
Ribosomes from Escherichia coli merodiplods heterozygous for resistance to streptomycin and to spectinomycin. J Mol Biol (1968) 1.92
Loss of transferrin receptor activity in Neisseria meningitidis correlates with inability to use transferrin as an iron source. Infect Immun (1988) 1.91
Qualitative and quantitative evaluation of six algorithms for correcting intensity nonuniformity effects. Neuroimage (2001) 1.90
Brain parenchyma motion: measurement with cine echo-planar MR imaging. Radiology (1992) 1.90
Genetics of resistance in a non-beta-lactamase-producing gonococcus with relatively high-level penicillin resistance. Antimicrob Agents Chemother (1986) 1.90
Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae. J Infect Dis (1986) 1.90
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis (2000) 1.89
Sequence-specific DNA uptake in transformation of Neisseria gonorrhoeae. J Bacteriol (1982) 1.86
Mutations to increased antibiotic sensitivity in naturally-occurring gonococci. Nature (1978) 1.83
Neisseria meningitidis produces iron-regulated proteins related to the RTX family of exoproteins. J Bacteriol (1993) 1.83
Gonococcal infection: a model of molecular pathogenesis. N Engl J Med (1985) 1.82
Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J Exp Med (1994) 1.80
Sexually transmitted diseases in the People's Republic of China in Y2K: back to the future. Sex Transm Dis (2000) 1.80
Genetic locus (nmp-1) affecting the principal outer membrane protein of Neisseria gonorrhoeae. J Bacteriol (1980) 1.80
Transformation-derived Neisseria gonorrhoeae plasmids with altered structure and function. J Bacteriol (1979) 1.78
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS (1999) 1.76
The MtrD protein of Neisseria gonorrhoeae is a member of the resistance/nodulation/division protein family constituting part of an efflux system. Microbiology (1997) 1.76
Two genetic loci for resistance to kasugamycin in Escherichia coli. J Bacteriol (1973) 1.75
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Transport of glucose, gluconate, and methyl alpha-D-glucoside by Pseudomonas aeruginosa. J Bacteriol (1974) 1.75
Acquiring simultaneous EEG and functional MRI. Clin Neurophysiol (2000) 1.75
Aerobactin utilization by Neisseria gonorrhoeae and cloning of a genomic DNA fragment that complements Escherichia coli fhuB mutations. J Bacteriol (1987) 1.72